Inactive Instrument

Calendar Geovax Labs Inc OTC Bulletin Board

Equities

End-of-day quote OTC Bulletin Board
- USD - Intraday chart for Geovax Labs Inc

Chart calendar Geovax Labs Inc

00c4b5f9a4af533d5fddbb545.-OXvJQFZs_uwV3c8xfpv_tD5nOU2v42XgjRoCtVKyZs.jYmLFiwoybb5H0JMscoqv5qc6dxH58nT220gXpNz-aKtiN19UBTfrZ1lNg~a5f1a5a6af0e3672b659b539730af40f

Upcoming events on Geovax Labs Inc

2024-05-01 Q1 2024 Earnings Release (Projected)
2024-05-30 American Society of Clinical Oncology Annual Meeting
2024-06-02 Bio International Convention
2024-08-12 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2024-11-12 Vaccines Summit
2025-03-25 Q4 2024 Earnings Release (Projected)

Past events on Geovax Labs Inc

2024-04-04 12:00 pm World Vaccine Congress
2024-03-18 05:30 pm Roth Conference
2024-02-29 04:30 pm Q4 2023 Earnings Call
2024-02-29 04:00 pm Q4 2023 Earnings Release
2024-02-26 04:15 pm BIO CEO & Investor Conference
2024-01-30 Reverse Split: 1 of 15
2024-01-08 05:30 pm Biotech Showcase
2023-12-06 03:25 pm Emerging Growth Conference
2023-12-04 10:00 am Noble Capital Markets Emerging Growth Equity Conference
2023-11-30 04:40 pm West Coast World Vaccine Congress
2023-11-28 07:20 pm West Coast World Vaccine Congress
2023-11-14 08:00 am Vaccines Summit
2023-11-08 04:30 pm Q3 2023 Earnings Call
2023-11-08 04:00 pm Q3 2023 Earnings Release
2023-11-05 Bio-Europe Conference
2023-11-02 03:55 pm Emerging Growth Virtual Conference
2023-10-12 01:30 pm Dawson James Small Cap Growth Conference
2023-10-05 03:30 pm BioFuture
2023-10-04 03:25 pm Emerging Growth Conference
2023-09-16 Molecular and Cellular Biology Keystone Symposium

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


1,82
0,00
-
0,39
0,22
75.23%
0,08
0,06
34.38%
0,00
0,00
-

0,00

EBITDA
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
-13,1
-9,30
-40.46%
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


-2,82
-2,08
-35.49%
-18,7
-7,48
-150.55%
-14,0
-13,8
-1.58%
-26,7
-24,1
-11.15%

-32,4

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-2,96
-2,22
-33.19%
-18,6
-7,14
-160.23%
-14,0
-13,8
-1.54%
-26,0
-23,2
-11.71%

-31,7

Net income
Million USD
Released
Forecast
Spread
-2,37


-2,96
-2,22
-33.19%
-18,6
-7,14
-160.23%
-14,0
-13,8
-1.54%
-26,0
-23,2
-11.71%

-31,7

EPS
USD
Released
Forecast
Spread
-11 775


-32,1
-4,05
-692.59%
-45,6
-17,7
-157.63%
-12,4
-12,0
-3.75%
-14,3
-14,5
1.79%

-10,0

Announcement Date24/03/2023/03/2109/03/2223/03/2329/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,16
0,00
-
0,08
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-13,7
-2,48
-454.18%
-2,43
-2,84
14.51%
-2,24
-2,84
20.92%
-3,97
-2,50
-58.82%
-5,39
-5,12
-5.16%
-4,27
-5,93
27.92%
-6,18
-4,55
-35.8%
-8,60
-6,00
-43.33%
-7,69
-7,43
-3.62%












Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-13,7
-2,48
-454.15%
-2,43
-2,84
14.52%
-2,24
-2,84
20.92%
-3,97
-2,50
-58.72%
-5,38
-5,12
-5.1%
-4,04
-5,92
31.84%
-5,93
-4,46
-32.97%
-8,41
-5,83
-44.15%
-7,59
-7,34
-3.48%












Net income
Million USD
Released
Forecast
Spread
-13,7
-2,48
-454.15%
-2,43
-2,84
14.52%
-2,24
-2,84
20.92%
-3,97
-2,50
-58.72%
-5,38
-5,12
-5.1%
-4,04
-5,92
31.84%
-5,93
-4,46
-32.97%
-8,41
-5,83
-44.15%
-7,59
-7,34
-3.48%












EPS
USD
Released
Forecast
Spread
-33,6
-6,00
-460%
-5,10
-4,65
-9.68%
-2,70
-4,50
40%
-2,55
-1,80
-41.67%
-3,00
-3,00
0%
-2,25
-3,38
33.33%
-3,30
-2,55
-29.41%
-4,80
-3,60
-33.33%
-3,94
-4,20
6.19%

-5,56


-5,82


-1,61


-1,74

Announcement Date09/03/2227/04/2203/08/2209/11/2223/03/2304/05/2309/08/2308/11/2329/02/24----